Oneness Biotech Co., Ltd. (4743.TWO)
TWD 87.4
(-2.13%)
TWD 87.4
(-2.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 86.78 Million | 1.06 Billion | 65.76 Million | 41.6 Million | 13.47 Million | 18.85 Million |
| Cost of Revenue | 54.22 Million | 221.16 Million | 20.72 Million | 10.88 Million | 17 Million | 10.2 Million |
| Gross Profit | 32.56 Million | 844.39 Million | 45.04 Million | 30.71 Million | -3.52 Million | 8.64 Million |
| Operating Expenses | 1.12 Billion | 1.08 Billion | 923.18 Million | 703.89 Million | 308.2 Million | 140.83 Million |
| Selling, General and Administrative Expenses | 176.63 Million | 166.82 Million | 117.22 Million | 107.54 Million | 69.56 Million | 45.97 Million |
| Research and Development Expenses | 952.54 Million | 919.01 Million | 805.96 Million | 589.28 Million | 238.63 Million | 94.43 Million |
| Other Expenses | - | 556.63 Million | 176.84 Million | 7.06 Million | 35.7 Million | -91.09 Million |
| Cost and Expenses | 1.18 Billion | 1.3 Billion | 943.9 Million | 714.77 Million | 325.2 Million | 151.04 Million |
| Operating Income | -1.09 Billion | 456.22 Million | -391.06 Million | -244.76 Million | -320 Million | -132.18 Million |
| Interest Expense | 5.61 Million | 4.59 Million | 4.89 Million | 5.17 Million | 6.25 Million | 6000.00 |
| Income Tax Expense | 5.29 Million | 99.73 Million | 16.86 Million | 1.73 Million | 2.2 Million | -112.74 Million |
| Earnings before Tax | -818.5 Million | 451.62 Million | -395.96 Million | -249.94 Million | -326.26 Million | -244.94 Million |
| Net Income | -1.31 Billion | 359.97 Million | -412.82 Million | -251.67 Million | -328.46 Million | -235.43 Million |
| Earnings Per Share Basic | -2.77 | 0.82 | -0.95 | -0.62 | -1.15 | -1.06 |
| Earnings Per Share Diluted | -2.77 | 0.80 | -0.95 | -0.62 | -1.15 | -1.05 |
| Weighted Average Shares Outstanding | 473.4 Million | 441.48 Million | 433.7 Million | 406.01 Million | 285.74 Million | 222.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 473.4 Million | 447.94 Million | 433.7 Million | 406.01 Million | 285.74 Million | 223.64 Million |
| Gross Margin | 0.38 | 0.79 | 0.68 | 0.74 | -0.26 | 0.46 |
| EBIT Margin | -7.77 | 0.89 | -2.95 | -1.25 | -18.84 | -12.37 |
| Profit Margin | -15.13 | 0.34 | -6.28 | -6.05 | -24.38 | -12.49 |
| EBITDA | -674.22 Million | 860.35 Million | -474.51 Million | -52.14 Million | -259.55 Million | -211.87 Million |
| Earnings Before Tax Margin | -12.64 | 0.43 | -5.95 | -5.88 | -23.75 | -7.01 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 30.78 Million | 25.81 Million | 86.78 Million | 25.67 Million | 19.02 Million | 19.89 Million |
| Cost of Revenue | 125.4 Million | 121.51 Million | 468.47 Million | 125.74 Million | 12.27 Million | 13.49 Million |
| Gross Profit | -94.62 Million | -95.7 Million | -381.69 Million | -100.07 Million | 6.75 Million | 6.39 Million |
| Operating Expenses | 186.62 Million | 164.67 Million | 714.93 Million | 197.51 Million | 275.84 Million | 285.88 Million |
| Selling, General and Administrative Expenses | 62.19 Million | 51.09 Million | - | 43.03 Million | 41.55 Million | 43.84 Million |
| Research and Development Expenses | 124.43 Million | 113.58 Million | - | 154.48 Million | 234.28 Million | 242.04 Million |
| Other Expenses | 80.07 Million | 230.48 Million | -1.12 Billion | -306.37 Million | 202.27 Million | 132.21 Million |
| Cost and Expenses | 312.02 Million | 286.19 Million | 1.18 Billion | 323.26 Million | 288.12 Million | 299.37 Million |
| Operating Income | -281.24 Million | -260.38 Million | -1.09 Billion | -297.58 Million | -222.86 Million | -324.9 Million |
| Interest Expense | 2.44 Million | 2.44 Million | 5.61 Million | 2.24 Million | 1.11 Million | 1.12 Million |
| Income Tax Expense | 912 Thousand | 403 Thousand | 5.29 Million | 505 Thousand | 1.69 Million | 2.61 Million |
| Earnings before Tax | -126.99 Million | 43.14 Million | -818.5 Million | -505.27 Million | -223.98 Million | -326.02 Million |
| Net Income | -173.32 Million | -92.62 Million | -1.31 Billion | -486.31 Million | -226.62 Million | -335.24 Million |
| Earnings Per Share Basic | -0.35 | -0.20 | - | -1.02 | -0.50 | -0.74 |
| Earnings Per Share Diluted | -0.35 | -0.20 | - | -1.02 | -0.50 | -0.74 |
| Weighted Average Shares Outstanding | 502.01 Million | 454.94 Million | 473.4 Million | 476.22 Million | 453.21 Million | 450.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 502.01 Million | 454.94 Million | 473.4 Million | 476.22 Million | 453.21 Million | 450.25 Million |
| Gross Margin | -3.07 | -3.71 | -4.40 | -3.90 | 0.35 | 0.32 |
| EBIT Margin | -5.28 | -5.51 | - | -6.98 | -5.93 | -10.76 |
| Profit Margin | -5.63 | -3.59 | -15.13 | -18.94 | -11.91 | -16.85 |
| EBITDA | -162.39 Million | -142.26 Million | - | -179.1 Million | -112.76 Million | -214.06 Million |
| Earnings Before Tax Margin | -9.14 | -10.09 | -12.64 | -11.59 | -11.71 | -16.33 |
SRTTY
CMPC
HYZN
LEDS
AEYGQ
3260